Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma — Stella

Home/Scleroderma/

View on ClinicalTrials.gov

Recruiting

Back to Scleroderma trials

Trial locations(1 site)

France

CHU Dijon Bourgogne, Dijon

Key details

Sponsor

Centre Hospitalier Universitaire Dijon

Enrollment target

~60 participants

Started

January 2026

Primary completion

January 2027

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.